AtmanCo Inc. ("AtmanCo" or the "Company") (TSX VENTURE:ATW) has filed its
consolidated interim financial statements for the quarter ended March 31, 2013.


Highlights of the First Quarter of 2013



--  Increase in consolidated sales by the Company of almost 300%, rising
    from $118,675 to $353,879, due in part to the reverse takeover. 
--  Increase in sales in the human resources sector of $97,660,
    approximately 82% higher than the previous comparable period, as well as
    an increase in the gross margin from 73% to 90%. 
--  Deferred revenues of $284,628 on May 31, 2013. 
--  Translation of the Atman Test into three additional languages
    (complementing the languages currently available, i.e. English, French
    and Spanish) to enable the development of new markets (Portuguese,
    German and Dutch). 



Activity Summary 

During the first quarter of 2013, sales by the Company improved $235,222 over
the quarter ended February 29, 2012. This increase is due to the reverse
takeover as well as a sales augmentation in the human resources sector. AtmanCo
increased its efforts with potential partners and customers to develop new
markets, notably in Europe. In addition, the Atman Test was revised and
translated into three additional languages, enabling the Company to reach the
Portuguese, German and Dutch markets.


These international efforts ran concurrent to development initiatives closer to
home, with AtmanCo announcing it had entered into a partnership with Canadian
telecommunications leader Videotron for the use of the platform of psychometric
tests developed by AtmanCo and the creation of corporate standards. 




----------------------------------------------------------------------------
(in thousands                 January 1, 2013              December 1, 2011 
 of $)                                     to                            to 
                               March 31, 2013             February 29, 2012 
----------------------------------------------------------------------------
                    Human                          Human                    
                Resources  Cyberhealth  Total  Resources  Cyberhealth Total 
               -------------------------------------------------------------
Products              216          138    354        119                119 
Cost of goods                                                               
 sold                                                                       
Depreciation           22           43     65         33                 33 
Other                               75     75                               
----------------------------------------------------------------------------
Gross margin          194           20    214         86                 86 
                       90%          14%    60%        73%                73%
                                                                            
----------------------------------------------------------------------------
                                                                            
----------------------------------------------------------------------------
(in thousands                                                               
of $)                          March 31, 2013             December 31, 2012 
----------------------------------------------------------------------------
Deferred                                                                    
 revenues             186           99    285        161           13   174 
----------------------------------------------------------------------------



Excluding depreciation, the Company saw its gross margin increase by $170,000
over the comparable quarter. 


The results for the quarter ended February 29, 2012 do not include the results
associated with the Company's cyberhealth activities since the reverse takeover
took place on October 18, 2012. Since quarters do not end on the same day, the
Company used the fiscal period ended February 29, 2012 for analysis purposes as
comparable quarter, given that these data are the most reflective of the current
period.


Changes to the Board of Directors 

In January 2013, the Company appointed Susan Kudzman as a board member of
AtmanCo. In April 2013, Catherine Loubier left her position as a member of the
AtmanCo Board of Directors. 


The above data comprise a summary of highlights. For further information, please
consult the Company's consolidated financial statements as well as the
Management Report for the fiscal quarter ended March 31, 2013, at www.sedar.com.



About AtmanCo

Field of human ressources

AtmanCo helps executives and managers recruit qualified human resources and
place the right person in the right position. AtmanCo created the Atman
personality test - a simple, accurate and scientifically proven psychometric
test with four modules: At-Plus, At-Model, At-Matchand At-Team. Each test and
its modules identify factors that shape an individual's personality and
influence their performance. User-friendly and easy to use, these proven tools
for developing human potential integrate easily into the recruitment,
organizational evaluation, and talent management processes.


Field of cyberhealth

The Company's mission is to provide corporations as well as health and physical
conditioning professionals with the means to enhance the value and efficiency of
their customer services, to offer personalized corrective solutions for posture
and physical condition, including exercise programs and eventually innovative
orthoses destined to improve the well-being of people suffering from backaches
or other musculoskeletal disorders and to improve people's physical and mental
condition as well as their general health, by harnessing leading edge
technologies in the fields of posture and biomechanics.


The Company stands out in its marketing approach via its Web site, direct sales
and partner network. For further information, visit www.atmanco.com and
www.biotonix.com sites.


This press release contains forward-looking statements that reflect the
Company's current expectation regarding future events. There is a risk that
expectations and forward looking statements will not prove to be accurate.
Readers are cautioned not to place undue reliance on these forward looking
statements as they involve risks and uncertainties, which could make actual
results differ materially from those projected herein and depend on a number of
factors including, but not limited to, no history of profitability, future
financing, intellectual property and patents, key personnel, competitive
marketplace, technology obsolescence, share price volatility and other risks
detailed from time to time in the Company's filings. While AtmcanCo anticipates
that subsequent events and developments may cause its views to change, AtmcanCo
specifically disclaims any obligation to update these forward looking
statements, unless obligated to do so by applicable securities laws.


FOR FURTHER INFORMATION PLEASE CONTACT: 
SOURCE:
AtmanCo Inc.
Michel Guay
President and CEO
514.935.5959 ext. 301
www.atmanco.com

Grafico Azioni ATW Tech (TSXV:ATW)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di ATW Tech
Grafico Azioni ATW Tech (TSXV:ATW)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di ATW Tech